Tanizawa, Yukio

Japanese clinical practice guideline for diabetes 2019

Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International

Diabetes Treatment and ManagementClinical practice guidelines implementation

Cited by 545

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 313

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 164

Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning

Chiu, K. C., Go, R. C. P., Aoki, M., Riggs, A. C., Tanizawa, Y., Acton, R. T., Bell, D. S. H., Goldenberg, R. L., Roseman, J. M., & Permutt, M. A. (1994) · Diabetologia

Pancreatic function and diabetesGestational Diabetes Research and Management

Cited by 49